These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1553062)

  • 1. [Piperacillin: comparison of antibacterial activity in vitro during the triennium 1986-88 versus the biennium 1981-82].
    Farris AG; Goffi MB
    Minerva Med; 1992 Mar; 83(3):141-4. PubMed ID: 1553062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility survey of piperacillin/tazobactam and some beta-lactam comparators in Italy.
    Stefani S; Bonfiglio G; Bianchi C; Zollo A; Nicoletti G
    Drugs Exp Clin Res; 1998; 24(2):105-13. PubMed ID: 9675551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Drugs Exp Clin Res; 1987; 13(9):555-61. PubMed ID: 3480796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibacterial activity of imipenem and other agents against gram-negative and gram-positive strains isolated from clinical specimens.
    Bartoloni A; Colao MG; Giganti E; Orsi A; Aquilini D; Corti G; Paradisi F
    G Ital Chemioter; 1988; 35(1-3):1-5. PubMed ID: 3256508
    [No Abstract]   [Full Text] [Related]  

  • 6. In-vitro activity of piperacillin and tazobactam combination against clinically significant bacteria.
    Obi CL; Makandiramba B; Robertson V; Tswana SA; Moyo SR; Nziramasanga P
    East Afr Med J; 1998 Mar; 75(3):162-5. PubMed ID: 9640815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Schmalreck AF; Wildfeuer A
    Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibacterial activity of mezlocillin against gram-negative and gram-positive bacteria from clinical isolates].
    Ravizzola G; Foresti I; Minelli F
    G Ital Chemioter; 1985; 32(2):277-80. PubMed ID: 3833562
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urinary infection. I. Comparative in vitro activities of several antibiotic drugs against Gram-negative bacteria].
    Giachino F; Allocco A; Tuninetti L; Tullio V; Cuffini AM; Carlone NA
    G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):55-67. PubMed ID: 7498617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activity of imipenem against gram-positive and gram-negative aerobic bacteria from clinical isolates.
    Bastianini L; Sposini T; Bartoli A; Marconi P
    Microbiologica; 1988 Apr; 11(2):137-42. PubMed ID: 3165489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiological characterization of dactimicin: antibacterial activity towards gram-positive and gram-negative bacteria.
    Stefani S; Debbia EA; Schito GC; Russo G
    Drugs Exp Clin Res; 1989; 15(3):119-23. PubMed ID: 2752910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro evaluation of the antibiotic effect of imipenen on bacterial strains isolated mostly from compromised patients].
    Bartolucci M; Galluzzi F; Sanchioni G; Aureli G
    Quad Sclavo Diagn; 1988; 24(1-4):203-12. PubMed ID: 3268913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Patterns of susceptibility to 19 antibiotics of bacteria isolated from blood cultures in a reference hospital in Mexico City].
    Giraud MC; Calva JJ; Huazano F; Ponce de León S; Ruiz-Palacios G
    Rev Invest Clin; 1986; 38(1):7-14. PubMed ID: 3738270
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro study of the antibacterial activity of cefotetan compared with piperacillin and ceftriaxone against bacterial strains isolated from pathological material of hospital patients.
    Gatti M; Varoli O; Piscolla F
    J Chemother; 1989 Jul; 1(4 Suppl):103-4. PubMed ID: 16312324
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro activity of the combination trimethoprim plus sulfamethoxazole compared with that of other chemotherapeutic agents.
    Focht J; Klietmann W; Nösner K
    Arzneimittelforschung; 1988 Aug; 38(8):1085-8. PubMed ID: 3264166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the in vitro activity of aztreonam on 1990 gram-negative bacterial strains recently isolated in Campania hospitals].
    Covelli I; Bolletti-Censi M; Fortunato A; Guarino A; Spagnoletti G; Amato G; Nani E; Anzivino D; Lavitola A; Gulletta E
    Boll Ist Sieroter Milan; 1986; 65(1):22-31. PubMed ID: 3521671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004).
    Bouchillon SK; Hoban DJ; Johnson BM; Johnson JL; Hsiung A; Dowzicky MJ;
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):173-9. PubMed ID: 16105561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro susceptibility of gram-negative bacteria isolated from urinary tract infections to acylureidopenicillins].
    Cerikcioğlu N; Ustaçelebi S; Günalp A
    Mikrobiyol Bul; 1986 Jul; 20(3):139-44. PubMed ID: 3561279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the in vitro activity of ertapenem and nine other comparator agents against 337 anaerobic bacteria.
    Behra-Miellet J; Dubreuil L; Calvet L
    Int J Antimicrob Agents; 2006 Jul; 28(1):25-35. PubMed ID: 16757152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.